Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease
We performed a retrospective analysis of the patients assessed at our memory unit for whom Alzheimer disease (AD) cerebrospinal fluid biomarker results were available. We selected patients diagnosed with mild cognitive impairment due to AD (National Institute on Aging-Alzheimer’s Association clinica...
Main Authors: | R. López-Cuevas, M. Baquero-Toledo, A. Cuevas-Jiménez, N. Martín-Ibáñez, R. Pascual-Costa, M.J. Moreno-Monedero, A. Cañada-Martínez, C. Peña-Bautista, I. Ferrer-Cairols, L. Álvarez-Sánchez, C. Cháfer-Pericás |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2023-05-01
|
Series: | Neurología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580823000068 |
Similar Items
-
Clinical and Neuropsychological Profile of Possible Alzheimer subtype neurocognitive disorder
by: Carmen María Ocaña Montoya, et al.
Published: (2019-10-01) -
Biomarkers of Alzheimer disease in mild cognitive impairment: Experience in a memory clinic from Latin America
by: R.F. Allegri, et al.
Published: (2021-04-01) -
Disfagia en adultos mayores mexicanos con deterioro cognitivo leve y demencia
by: Georgina Martínez-Peña, et al.
Published: (2024-07-01) -
Deterioro cognitivo leve: ¿dónde termina el envejecimiento normal y empieza la demencia?
by: Nilton Custodio, et al.
Published: (2012-10-01) -
Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson
by: Beatriz Elena Muñoz Ospina, et al.
Published: (2019-09-01)